Search results
Merck Expands Access to High-Quality Maternal Care for More Than 30 Million Women Worldwide Through ...
Morningstar· 7 days agoRAHWAY, NJ / ACCESSWIRE / May 8, 2024 / Merck (NYSE:MRK), known as MSD outside of the United States and Canada, announced today that Merck for Mothers, ...
Bars, music venues left in limbo after South Carolina lawmakers fail to address liquor liability
WYFF 4 Greenville· 12 hours agoBar and music owners will now have to wait until next year to hopefully get help from lawmakers in...
Merck Ends Co-Formulation Arm of Keytruda High-Risk Melanoma Study
Market Watch· 2 days agoMerck & Co. has ended part of a late-stage study of a co-formulation of its blockbuster cancer drug Keytruda in certain skin-cancer patients because the study was likely to ...
Merck’s trial of KEYTRUDA regimen fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 5 days agoMerck has announced that its Phase III KEYNOTE-B21 (ENGOT-en11/GOG-3053) clinical trial of KEYTRUDA...
Merck's endometrial cancer therapy fails trial
AOL· 6 days agoThe drugmaker's Keytruda therapy in combination with chemotherapy was being evaluated in about 1,095 patients with high-risk endometrial cancer after surgery. The trial did not meet the main ...
Merck halts research on combo drug for skin cancer
Becker’s Hospital Review· 2 days agoMerck will stop testing an experimental combination treatment for skin cancer patients in a late-stage study, the drugmaker said May 13. Merck was evaluating ...
Merck stops skin cancer combination therapy testing in late-stage study
Reuters via Yahoo Finance· 2 days agoMay 13 (Reuters) - Merck said on Monday it had discontinued the arm of a late-stage study, which tested an experimental antibody-based drug with its blockbuster immunotherapy ...
Merck to Participate in the Bank of America Securities 2024 Healthcare Conference
Morningstar· 7 days agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Caroline Litchfield, executive vice president and chief financial officer, is ...
2 No-Brainer Dividend Stocks to Buy in May
Motley Fool via Yahoo Finance· 6 days agoThe oncology market is known for its strong pricing power, with cancer drugs typically carrying high price tags and significant margins. While Pfizer's...
Absci Corp (ABSI) Q1 2024 Earnings Call Transcript Highlights: Strategic Advancements and ...
GuruFocus.com via Yahoo Finance· 3 hours agoAbsci Corp (NASDAQ:ABSI) has established valuable partnerships with industry leaders such as Merck and AstraZeneca, which helps leverage their platform and advance drug discovery ...